Login to Your Account



Pharma: Other News To Note


Friday, June 29, 2012
• Astellas Pharma Inc., of Tokyo, said the FDA approved Myrbetriq (mirabegron) to treat adults with overactive bladder.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription